AlphaFold predicted structure
C1GALT1C1 · Q96EU7

Mean pLDDT
87.2/ 100
Confident
318 residues
Confidence breakdown
- Very high(≥ 90)62%
- Confident(70–90)25%
- Low(50–70)10%
- Very low(< 50)4%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
C1GALT1 specific chaperone 1
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Fetal anomalies
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesCongenital disorders of glycosylation
Other - please specify in evaluation commentsLikely inborn error of metabolism
Other - please specify in evaluation commentsUndiagnosed metabolic disorders
Other - please specifiy in evaluation commentshemolytic uremic syndrome, atypical, 8, with rhizomelic short stature
neurodegenerative disease
carcinoma
atypical hemolytic-uremic syndrome
Abnormal protein O-linked glycosylation
breast cancer
colorectal carcinoma
breast carcinoma
cancer
anti-neutrophil antibody associated vasculitis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
C1GALT1-specific chaperone 1
Probable chaperone required for the generation of 1 O-glycan Gal-beta1-3GalNAc-alpha1-Ser/Thr (T antigen), which is a precursor for many extended O-glycans in glycoproteins. Probably acts as a specific molecular chaperone assisting the folding/stability of core 1 beta-3-galactosyltransferase (C1GALT1)
C1GALT1C1 · Q96EU7

Mean pLDDT
87.2/ 100
Confident
318 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0